Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Source And Potency Of Stem Cells
Tissue Renewal without Stem Cells
Liver Regeneration
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 3, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
R E Schwartz1, H E Fleming2, S R Khetani3
1Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital, USA.
Induced pluripotent stem cell-derived hepatocyte-like cells (iHLCs) offer potential for liver disease research and therapy. However, iHLCs exhibit immature functions, limiting their clinical application.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: